TXMD financial statements and SEC filings
TXMD annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $3.02M | -$4.39M | -$569.00K | 10-K/A |
| 2024-12-31 | $1.76M | -$6.11M | -$2.18M | 10-K/A |
| 2023-12-31 | $1.30M | -$8.52M | -$10.28M | 10-K |
| 2022-12-31 | $69.96M | $1.19M | $112.00M | 10-K |
| 2021-12-31 | $2.57M | -$79.58M | -$172.41M | 10-K |
| 2020-12-31 | $64.87M | -$155.54M | -$183.52M | 10-K |
TXMD annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $37.66M | $10.78M | $26.88M | 10-Q |
| 2024-12-31 | $38.82M | $11.45M | $27.37M | 10-K/A |
| 2023-12-31 | $43.31M | $14.02M | $29.29M | 10-K |
| 2022-12-31 | $90.46M | $55.31M | $35.14M | 10-K |
| 2021-12-31 | $169.47M | $263.09M | -$93.62M | 10-K |
| 2020-12-31 | $181.61M | $305.61M | -$124.00M | 10-K |
TXMD annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $2.42M | – | – | 10-K/A |
| 2024-12-31 | $732.00K | – | – | 10-K/A |
| 2023-12-31 | -$48.14M | – | $3.15M | 10-K |
| 2022-12-31 | -$4.08M | – | – | 10-K |
| 2021-12-31 | -$142.69M | -$34.00K | $129.55M | 10-K |
| 2020-12-31 | -$159.47M | -$207.00K | $80.72M | 10-K |